Scientists test new brain drug on healthy people using ketamine
NCT ID NCT03844906
Summary
This early-stage study tested an experimental drug called SAGE-718 in 40 healthy volunteers. Researchers gave participants either SAGE-718 or a placebo, then used a low dose of ketamine to temporarily alter brain activity and measure the drug's effects. The main goals were to check the drug's safety, see how it affects brain signals, and understand how the body processes it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sage Investigational Site
Long Beach, California, 90806, United States
-
Sage Investigational Site
Berlin, New Jersey, 08009, United States
Conditions
Explore the condition pages connected to this study.